Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Research Domains

Molecular detection of colorectal neoplasia.

David A Ahlquist1

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. ahlquist.david@mayo.edu <ahlquist.david@mayo.edu>

Gastroenterology
|April 28, 2010

Related Experiment Videos

View abstract on PubMed

Summary
This summary is machine-generated.

Related Concept Videos

  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Molecular Detection Of Colorectal Neoplasia.

    • Noninvasive molecular tests for colorectal cancer, particularly advanced stool-based methods, show high accuracy in detecting cancers and precancerous lesions. Further validation in average-risk populations is crucial for widespread adoption in colorectal cancer screening.

    Area of Science:

    • Oncology
    • Molecular Diagnostics
    • Gastroenterology

    Background:

    • Colorectal cancer screening effectiveness and user-friendliness can be improved with noninvasive molecular approaches.
    • Current screening methods have limitations, driving the need for innovative solutions.
    • Molecular markers in biological samples offer a promising avenue for early detection.

    Purpose of the Study:

    • To review the biological rationale behind molecular screening for colorectal cancer.
    • To discuss technical advancements in noninvasive molecular detection methods.
    • To summarize clinical performance data and identify remaining challenges for molecular colorectal cancer screening.

    Main Methods:

    • Review of scientific literature on molecular markers for colorectal cancer.
    • Analysis of next-generation stool-based tests and other noninvasive assays.
    • Evaluation of clinical performance data for accuracy in detecting colorectal cancer and precancerous lesions.

    Main Results:

    • Noninvasive molecular tests, especially stool-based assays, demonstrate high accuracy for detecting colorectal cancer and precancerous lesions.
    • Emerging technologies show potential for improved screening effectiveness and user-friendliness.
    • Significant progress has been made in assay sensitivity and specificity.

    Conclusions:

    • Molecular screening holds considerable promise for enhancing colorectal cancer detection.
    • Validation in average-risk populations is essential to establish the role of these tests in general screening guidelines.
    • Continued research and development are needed to address remaining issues and optimize implementation.

    Related Experiment Videos